ArticleJournal of medical case reports2026
Late-onset dyskeratosis congenita due to a TERC (n.269G > C) variant-first reported case from Indonesia: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome caused by defective telomere maintenance. It often presents with mucocutaneous features, cytopenias, and progressive organ involvement, but remains underrecognized in resource-limited settings. CASE PRESENTATION: We report a 32-year-old Indonesian male of Javanese ethnicity who presented with progressive anemia, thrombocytopenia, and bilateral hip pain. Physical examination revealed long-standing reticulate hyperpigmentation and premature graying. Bone marrow evaluation showed aplastic anemia, requiring periodical packed red cells transfusions. Telomere length testing demonstrated markedly shortened telomeres, and genetic analysis identified a heterozygous TERC mutation (n.269G > C) in both the patient and his mother. The patient also developed avascular necrosis of both hips, requiring bilateral hip replacement.
conclusionThis case highlights the importance of considering telomere biology disorders such as DC in patients with unexplained cytopenias and premature aging features. Early recognition is essential to guide appropriate management and avoid potentially harmful therapies, particularly in resource-limited settings where these conditions may be underrecognized.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.